the National Veterinary School Alfort
Maisons-Alfort, 94700, France
Location status: Recruiting
NCT Number: NCT06262009
Humans in contact with animals such as dog owners, may be at risk of antimicrobial resistance (AMR) acquisition. This is the central issue to be investigated in DYASPEO
Interested in participating?
Request InfoAll sexes
Observational
Maisons-Alfort, 94700, France
Location status: Recruiting
Antimicrobial resistance (AMR) is a global and multifaceted public health problem. Advanced knowledge on AMR has demonstrated that it not only affects humans but is also widely distributed across animals and the environment. A major cause of the AMR burden refers to the capability of AMR to transmit within and between individuals, including between humans and animals. Leading examples of internationally distributed AMR bacteria are Enterobacterial disseminating resistances to extended-spectrum cephalosporins (ESC-E) and carbapenems (CP-E). Yet, the magnitude and pathways of their cross-sectorial transfers are poorly understood.
There is a great concern that humans in contact with animals be at risk of ESC-E/CP-E acquisition. Whereas an increase in ESC-E carriage in farmers in contact with their food-producing animals was reported, AMR transmission to humans through direct contacts with companion animals has been much less studied. Owing the close relationships between pets and owners, and the fact that 50% of households host a dog or a cat in France, the hypothesis of pet ownership being a risk for humans to acquire ESC-E/CP-E appears strongly relevant. The DYASPEO project will investigate this question through a combination of several approaches from field to laboratory studies, and including epidemiology, ecology, molecular and population genomics, studies on intestinal microbiota, modelling and social sciences.
We hypothesize that the interface between humans and companion animals plays a significant role in the transfer of ESC-E/CP-E. This hypothesis is corroborated (i) by recent data in France showing that antibiotic exposure of companion animals is still increasing contrary to all other animal host (e.g. food-producing animals) and (ii) by a recent study from the consortium demonstrating a high AMR prevalence in dogs getting back home after hospitalization.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
collecting stools 6 times over a 90 days period and complete a questionnaire at the same times: D1, D7, D15, D30, D60 and D90
interviews and/or ethnographic observations for 50 volunteers
Time frame: over the 90 days follow up
mathematical models combining all the data (epidemiological, bacteriological, genomic, sociological) gathered in the project
Time frame: over the 90 days follow up
Time frame: over the 90 days follow up
Time frame: over the 90 days follow up
Time frame: over the 90 days follow up
Time frame: over the 90 days follow up
Time frame: over the 90 days follow up
Time frame: during semi-directive interviews and/or observational periods
Contact information is provided by the study sponsor or research team.
Assistance Publique - Hôpitaux de Paris
Other
Acronym: Dyaspeo
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04460313
Antibiotic Resistant Strain, Children, Only
Créteil, France
View Trial DetailsNCT07631377
Actinomycetales Infections, Antibiotic Resistant Strain
View Trial DetailsNCT07013552
Antibiotic Resistant Strain, Antibiotic Therapy
Katowice, Silesian Voivodeship, Poland
View Trial DetailsNCT06583642
Antibiotic Resistant Strain, Bacterial Infections
Milan, Italy
View Trial Details